The base Jeep Grand Cherokee Laredo A starts at $36,495 and features a spacious interior along with great standard equipment. Its performance and list of amenities don’t stand out among ...
Takeda paid Protagonist $300 million one year ago to license rights to rusfertide, which the companies are developing to ...
Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a ...
Clinical Trials Arena on MSN4d
Takeda and Protagonist report topline outcomes from trial of rusfertideTakeda and Protagonist Therapeutics have reported positive topline outcomes from their Phase III VERIFY trial of rusfertide ...
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 V ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback